Medical Device News Magazine

MDIC Releases Best Practices for Communicating Benefit, Risk, and Uncertainty for Medical Devices: Register for 10/2/20 Webinar

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

September 11, 2020

The Medical Device Innovation Consortium (MDIC) has announced the release of Best Practices for Communicating Benefit, Risk, and Uncertainty for Medical Devices.

MDIC states the report focuses on providing evidence-based best practices for enhancing communication with patients about medical devices so that patients can make informed treatment decisions.

“Patients considering a medical device need to understand the implications of available treatment options. This report helps decision-makers better understand how to communicate in ways that will resonate with patients,” said Scott Goates, Ph.D., Senior Advisor of Health Economics and Outcomes Research at Abbott and Chair of the Science of Patient Input Communication Working Group. The working group wrote the report on behalf of MDIC’s Science of Patient Input Steering Committee.

The MDIC report identifies characteristics of providers and patients, and the way in which the scientific and medical information is disseminated, that can affect patients’ comprehension and decision-making.

“The patient perspective that is included in this report will help physicians and medical device manufacturers understand what patients really need,” says heart patient and patient advocate Heidi Dohse. “This report provides patient insights in a way that is actionable for physicians and medical device manufacturers.”

Dohse has been living with pacemakers for 37 years since she was diagnosed with irregular junctional tachycardia at age 19. Back then, no one told her that there were different types of pacemakers and her first pacemaker wasn’t responsive to her needs as an athlete. Within six months, Dohse had a second procedure to replace her first pacemaker with another pacemaker that was better suited to her needs and goals. Dohse shares her story in the report.

“Patient engagement during the treatment decision-making process is key. This requires that all medical device stakeholders understand how to appropriately communicate with patients about medical devices,” said Pamela Goldberg, MBA, President, and CEO of MDIC. “The report is a practical resource that summarizes key terms and provides evidence-based tools, and resources to help develop an effective communication strategy.”

The report is also part of a larger movement to “make sure the patient’s voice is front and center in making decisions about medical devices,” said Goates. That movement includes MDIC’s Science of Patient Input program, which focuses on integrating the patient’s perspective and preferences in the design, clinical development, and regulatory review of innovative medical technologies.

“It’s really important that MDIC is including the patient voice and listening to the patient perspective,” said Dohse.

Read Best Practices for Communicating Benefit, Risk, and Uncertainty for Medical Devices.

Register for the webinar on communicating benefit, risk, and uncertainty for medical devices on Friday, October 2, 2020, at 2 pm ET.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”